Related Experiment Video
Updated: May 28, 2026

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
Reduced bone mineral density in hypertensive patients is associated with left ventricular diastolic dysfunction, not
Hisashi Masugata1, Shoichi Senda, Koji Murao
1Department of Integrated Medicine, Kagawa University, Kagawa, Japan. masugata@med.kagawa-u.ac.jp
Insights
Reduced bone mineral density in hypertensive patients is linked to diastolic dysfunction, not left ventricular hypertrophy. This association suggests an increased risk for heart failure and bone fractures in this population.
Area of Science:
- Cardiology
- Bone Metabolism
Background:
- Hypertension is frequently associated with left ventricular (LV) hypertrophy and diastolic dysfunction, risk factors for heart failure.
- Reduced bone mineral density (BMD) has been observed in hypertensive individuals, but its relationship with cardiac abnormalities is unclear.
Purpose of the Study:
- To investigate the association between bone mineral density and LV hypertrophy and diastolic dysfunction in hypertensive patients.
Main Methods:
- Bone mineral density of the calcaneus was measured using quantitative ultrasound (stiffness index).
- Left ventricular mass index (LVMI) assessed LV hypertrophy via echocardiography.
- Left ventricular diastolic function evaluated using early diastolic mitral annular velocity (e') and E/e' ratio.
Main Results:
- No significant correlation was found between bone mineral density and LVMI.
- Bone mineral density showed a positive correlation with e' (r = 0.453, P < .01).
- Bone mineral density demonstrated a negative correlation with E/e' (r = -0.359, P < .05).
Conclusions:
- Reduced bone mineral density in hypertensive patients is associated with LV diastolic dysfunction, not LV hypertrophy.
- Hypertensive patients with low BMD may face elevated risks of heart failure due to diastolic dysfunction and osteoporosis-related fractures.
Abstract:
Left ventricular (LV) hypertrophy and diastolic dysfunction are commonly observed in hypertensive patients, and have been demonstrated to be risk factors of chronic heart failure due to LV diastolic dysfunction. Recently, reduced bone mineral density has been found in hypertensive patients compared with healthy controls. However, relationships between bone mineral density and LV hypertrophy and diastolic dysfunction have not been fully assessed. We examined relationships between bone mineral density and both LV hypertrophy and diastolic dysfunction in 38 hypertensive patients (23 males, 15 females; mean age 71 ± 8 y) who had been treated with antihypertensive drugs for at least 1 year. The bone mineral density of the calcaneus was measured with a quantitative ultrasound measurement device (A-1000 EXPRESS/InSight, GE Healthcare, Horten, Norway), and the stiffness index was determined as a parameter of bone mineral density. Echocardiography was performed to measure the left ventricular mass index as a parameter of LV hypertrophy. Left ventricular diastolic dysfunction was also assessed by early diastolic mitral annular velocity (e'), and the ratio of early transmitral flow velocity (E) to e' (E/e'). The bone mineral density did not correlate with left ventricular mass index, but did correlate with e' (r = 0.453, P < .01) and E/e' (r = -0.359, P < .05). Thus, reduced bone mineral density in hypertensive patients is not associated with LV hypertrophy but with LV diastolic dysfunction. Hypertensive patients with reduced bone mineral density may have a high risk of chronic heart failure due to LV diastolic dysfunction as well as bone fractures due to osteoporosis.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension III: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis I: Introduction
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Heart Failure Drugs: Diuretics
